CFTR and cystic fibrosis: Elevated extracellular iron and the associated increase in Pa biofilm formation and viability (Fig. 4b–d) suggest that dysfunctional iron metabolism in CF MDMs (1) impacts host–pathogen interactions and (2) may be sensitive to CFTR modulator therapy.